StageZero Life Sciences Ltd. (TSXV: SZLS.H)
Health Care · Biotechnology · CA
CA$—
— today · — 1Y
StageZero Life Sciences Ltd. (TSXV: SZLS.H) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.64M and employs 40 people.
trading between 0.04 and 0.10.
Tweenvest scores StageZero Life Sciences Ltd. across four factors: quality 14/100, value 67/100, growth 0/100. Its strongest factor is value.
SZLS.H price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.64M
- Revenue (TTM)
- $2.88M
- P/E
- —
- EPS
- -0.12
- Dividend yield
- —
- Beta (5Y)
- 0.31
- 52-week high
- CA$0.10
- 52-week low
- CA$0.04
- Avg volume (3M)
- —
- Shares outstanding
- 123.55M
- Employees
- 40
- Next earnings
- —
About StageZero Life Sciences Ltd.
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is Aristotle, a multi-cancer panel test for simultaneously screening for various cancers from a single sample of blood with high sensitivity and specificity for each cancer. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; COVID polymerase chain reaction testing and blood test analysis; Prostate Health Index, a screening test for prostate cancer; and BreastSentry, a test to determine a woman's risk for developing breast cancer. The company was founded in 1998 and is headquartered in Richmond Hill, Canada.
- ISIN
- CA8525403017
- Listed since
- Jan 7, 2004
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Genetic Analysis ASXSAT: GEAN | $3.82M | Nkr0.48 | -9.43% |
| Tissue Repair LtdASX: TRP | $3.78M | AU$0.09 | +9.76% |
| Eocene Ltd.NasdaqCM: EOCN | $3.76M | $3.46 | -4.22% |
| Bharat Immunologicals & Biologicals Corporation LimitedBSE: 524663 | $3.67M | Rs8.18 | -37.13% |
| Mustang Bio, Inc.NasdaqCM: MBIO | $3.57M | $0.45 | -4.44% |
| Nymox Pharmaceutical CorporationOTCPK: NYMX.F | $3.36M | $0.03 | -68.00% |
| Chosa Oncology ABNGM: CHOSA | $3.31M | Skr— | — |
| Restart Life Sciences Corp.CNSX: HEAL | $3.30M | CA$0.08 | +7.14% |
Figures last refreshed Oct 4, 2026.